Director, Global Commercial Strategy; Prostate Cancer

Position: Director, Global Commercial Strategy (Prostate Cancer)
# Director, Global Commercial Strategy (Prostate Cancer)
Raritan, United States Full time Marketing Oncology Director Notify me about similar jobs

View Full Job & Apply at Johnson & Johnson Johnson & Johnson is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.## About this opportunity

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
** Job Function:
** Marketing
* * Job Sub Function:
** Strategic Marketing
** Job Category:
** Professional
* * All Job Posting Locations:
** Raritan, New Jersey, United States of America
*
* Job Description:

** Johnson & Johnson Innovative Medicine is recruiting for a Director, Global Commercial Strategy (Prostate Cancer Early Development) in Raritan, NJ.
** About Innovative Medicine
** Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at
** Position Summary
** This position is responsible for leading a potentially transformational molecule in clinical development for prostate cancer, supported by compelling early clinical data and advancing rapidly into registrational studies. As a strategically important growth opportunity within the global J&J prostate cancer portfolio, the asset has the potential to address significant unmet patient needs, establish a differentiated treatment paradigm and create substantial long-term value.

The Director, Global Commercial Strategy will serve as the commercial asset strategy lead for a clinical stage asset in Prostate Cancer, shaping the asset's indication-expansion, lifecycle-management, and data-generation strategies to maximize global patient impact and enterprise value. Working at the intersection of Commercial, Medical, Market Access, R&D and regional organizations, this leader will translate complex clinical, competitive and market insights into differentiated development priorities, compelling value propositions and robust commercial forecasts.

The role will influence critical investment and portfolio decisions, align global and regional stakeholders around an integrated compound strategy, and mobilize a broad cross-functional network to accelerate development, strengthen launch readiness and optimize the long-term value of the J&J prostate cancer portfolio.
** Major

Duties & Responsibilities
** Own and lead the global commercial asset strategy for a clinical stage asset in Prostate Cancer across lifecycle and indication-expansion planning, and evidence-generation priorities, including the Integrated Evidence Generation Plan. Define the differentiated treatment opportunity and translate patient, customer and market needs into development choices that maximize launch potential, global adoption and long-term asset value.

Lead enterprise-wide engagement with regional organizations to synthesize commercial, medical and market access insights into an integrated global compound strategy. Build alignment on priority indications, target-product profiles, evidence requirements and market-shaping investments while ensuring regional needs inform development and launch-readiness  a cohesive compound-development and market-shaping strategy with Global Medical Affairs and Market Access leaders, integrating clinical, scientific, payer and customer perspectives.

Anticipate evidence and access barriers, shape solutions early and ensure the asset's clinical program supports a compelling and differentiated…